Appendix Table A7.
Distribution of Participant-reported Frequency of Diplopia and Change in Diplopia Frequency from Baseline by Treatment Group.
| Baseline | 4 weeks | 8 weeks | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||
| Participant-reporteda | Binocular Treatment |
Continued Spectacles |
Binocular Treatment |
Continued Spectacles |
Binocular Treatment |
Continued Spectacles |
||||||
|
|
||||||||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |
|
| ||||||||||||
| Per Group(N) | 91 | 90 | 87 | 84 | 86 | 84 | ||||||
|
| ||||||||||||
| Diplopia frequency b | ||||||||||||
| Never | 87 | 96% | 86 | 96% | 78 | 90% | 79 | 94% | 78 | 91% | 78 | 93% |
| Less than once a week | 2 | 2% | 0 | 0% | 2 | 2% | 2 | 2% | 4 | 5% | 4 | 5% |
| Once a week | 0 | 0% | 3 | 3% | 4 | 5% | 0 | 0% | 1 | 1% | 1 | 1% |
| Once a day | 1 | 1% | 1 | 1% | 3 | 3% | 3 | 4% | 2 | 2% | 0 | 0% |
| Up to 10 times a day | 1 | 1% | 0 | 0% | 0 | 0% | 0 | 0% | 1 | 1% | 0 | 0% |
| More than 10 times a day | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% |
| All the time | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% | 1 | 1% |
|
| ||||||||||||
| Change in diplopia frequency from baseline c | ||||||||||||
| Increased frequency (> 2 levels) | 6 | 7% | 2 | 2% | 2 | 2% | 1 | 1% | ||||
| Similar frequency (within 1 level) | 79 | 92% | 80 | 95% | 82 | 96% | 80 | 95% | ||||
| Reduced frequency (> 2 levels) | 1 | 1% | 2 | 2% | 1 | 1% | 3 | 4% | ||||
a
Three participants in the binocular treatment group (one at each visit) and one in the control treatment group at the 4-week visit had monocular diplopia.
b
The exact Wilcoxon rank sum test was used to compare diplopia frequency at 4 weeks (P = .36) and 8 weeks (P = .65) between the treatment groups.
c
The exact Wilcoxon rank sum test was used to compare the change in diplopia frequency from baseline to 4 weeks (P = .36) and to 8 weeks (P = .60) between the treatment groups.